Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.57 |
| ▸ | BAX | Q07812 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | SCN4A | P35499 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL403667 | 0.94 | LTA4H (0.71) | LTA4HTSHRALDH1A1NR1H2BAX | |
| Biphenyl SCHEMBL10838288 | 0.94 | LTA4H (0.71) | LTA4HTSHRALDH1A1NR1H2BAX | |
| SCHEMBL21921128 | 0.94 | LTA4H (0.71) | LTA4HTSHRALDH1A1NR1H2BAX | |
| SCHEMBL9190364 | 0.94 | LTA4H (0.71) | LTA4HTSHRALDH1A1NR1H2BAX | |
| SCHEMBL31588897 | 0.91 | LTA4H (0.67) | LTA4HTSHRALDH1A1NR1H2BAX | |
| SCHEMBL2860844 | 0.90 | LTA4H (0.75) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL6406035 | 0.90 | LTA4H (0.75) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL197414 | 0.90 | LTA4H (0.75) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL10686173 | 0.90 | LTA4H (0.65) | LTA4HTSHRALDH1A1NR1H2BAX | |
| SCHEMBL3681820 | 0.90 | LTA4H (0.65) | LTA4HTSHRALDH1A1NR1H2BAX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522556-B2 | Process for recovering acrylic acid | BASF SE (DE) | 2026-01-13 | — | — | US | claimed |
| EP-4650340-A1 | PROCESS FOR THE PREPARATION OF UNSATURATED SYMMETRICAL CARBOXYLIC ANHYDRIDES | Evonik Operations GmbH (DE) | 2025-11-19 | — | — | EP | claimed |
| WO-2025074249-A1 | NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER | PFIZER INC. (US) | 2025-04-10 | — | — | WO | claimed |
| CN-119591582-A | Imide-based proteolytic modulators and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-118420782-A | Protein purification method based on GEM particles and application | 吉林大学 | 2024-08-02 | — | — | CN | claimed |
| WO-2024106781-A1 | LIPID COMPOUND AND COMPOSITION FOR DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2024-05-23 | — | — | WO | claimed |
| CN-114439714-B | Tower type solar thermal power generation system adopting biphenyl and biphenyl ether mixture circulating working medium | 中国科学技术大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117777289-A | Humanized antibodies targeting CLDN18.2, derived products and their use in tumor therapy | 深圳豪石生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240034709-A1 | NOVEL PROCESS FOR CONTINUOUS PREPARATION OF METHACRYLIC ACID BY CATALYTIC HYDROLYSIS OF METHYL METHACRYLATE | RÖHM GMBH (DE) | 2024-02-01 | — | — | US | claimed |
| EP-4110752-B1 | METHOD FOR RECOVERING ACRYLIC ACID | BASF SE (DE) | 2024-01-31 | — | — | EP | claimed |
| CN-102875730-B | Method for preparing pyrethroid fragment imprinted polymer | INSPECTION AND QUARANTINE TECHNOLOGY CENTER, HENAN ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU (CN) | 2014-10-22 | — | — | CN | claimed |
| US-20140208753-A1 | METHOD FOR ENERGY STORAGE TO UTILIZE INTERMITTENT RENEWABLE ENERGY AND LOW-VALUE ELECTRICITY FOR CO2 CAPTURE AND UTILIZATION | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-07-31 | — | — | US | claimed |
| WO-2014042289-A1 | HEATING MEDIUM COMPOSITION FOR SOLAR THERMAL POWER GENERATION SYSTEM | TOKYO OHKA KOGYO CO., LTD. (JP) | 2014-03-20 | — | — | WO | claimed |
| US-20130231488-A1 | PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS; USE OF THE SAID COMPOUNDS OBTAINED VIA THE PROCESS IN THE SYNTHESIS OF SILOXANE COMPOUNDS CONTAINING A 2-HYDROXYPHENYLBENZOTRIAZOLE FUNCTION | L'OREAL (FR) | 2013-09-05 | — | — | US | claimed |
| EP-2632904-A1 | PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION | L'Oréal (FR) | 2013-09-04 | — | — | EP | claimed |
| CN-102875730-A | Method for preparing pyrethroid fragment imprinted polymer | HENAN ENTRY EXIT INSPECTION AND QUARANTINE BUREAU INSPECTION AND QUARANTINE TECHNOLOGY CT | 2013-01-16 | — | — | CN | claimed |
| WO-2012055063-A1 | PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION | L'OREAL (FR) | 2012-05-03 | — | — | WO | claimed |
| EP-1242382-B1 | TRICYCLIC PROTEIN KINASE INHIBITORS | WYETH CORP (US) | 2007-02-07 | — | — | EP | claimed |
| US-5725636-A | Gas dehydration process | GAS RESEARCH INSTITUTE (US) | 1998-03-10 | — | — | US | claimed |
| EP-0331312-B1 | PROCESS FOR PREPARING ELASTOMERIC POLYARYLATE GRAFT COPOLYMERS AND POLYARYLATE BEARING ONE DIHYDROCYCLOBUTENE END GROUP | AMOCO CORPORATION (US) | 1992-11-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231488-A1 | PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS; USE OF THE SAID COMPOUNDS OBTAINED VIA THE PROCESS IN THE SYNTHESIS OF SILOXANE COMPOUNDS CONTAINING A 2-HYDROXYPHENYLBENZOTRIAZOLE FUNCTION | HPD, PAH, SULT2A1 | LTA4H 325/4885TSHR 3941/4885ALDH1A1 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.